Clenbuterol

Clenbuterol 40mcg by Dragon Pharma

Clenbuterol is Dragon Pharma's formulation of Clenbuterol Hydrochloride at 40mcg per tablet — a beta-2 adrenergic agonist originally developed as a bronchodilator for asthma treatment, widely used in bodybuilding for its thermogenic and anti-catabolic properties. Supplied in a 100-tablet pack, Clenbuterol requires specific cycling protocols due to beta-2 receptor downregulation — a physiological mechanism that competitors consistently fail to explain properly.

Also searched as: Clenbuterol 40mcg, Clen tabs, Clenbuterol HCl, Clenbuterol Dragon Pharma.

How Clenbuterol Works — The Full Mechanism

Clenbuterol acts primarily as a beta-2 adrenergic receptor (β2-AR) agonist — but its effects extend across several biological systems:

• Thermogenesis: Beta-2 receptor activation in adipose tissue increases uncoupling protein expression and mitochondrial heat production — raising basal metabolic rate (BMR) by an estimated 5-10% above baseline in human studies. This translates to approximately 100-200 additional calories burned per day at therapeutic doses
• Lipolysis: β2-AR activation in adipocytes activates hormone-sensitive lipase (HSL) and increases intracellular cAMP, stimulating the breakdown of stored triglycerides into free fatty acids for oxidation
• Anti-catabolism: Less commonly explained — Clenbuterol also activates beta-2 receptors in skeletal muscle, increasing protein synthesis and reducing protein breakdown through mTOR pathway stimulation. This anti-catabolic effect is clinically documented and is why Clenbuterol is used in muscle-wasting conditions and why it's valued during caloric deficits where lean tissue preservation is a priority
• Bronchodilation: The original clinical indication — relaxation of bronchial smooth muscle via beta-2 receptor activation

Why 2-Week On/Off Cycling Is Mechanistically Required

This is the most important and most poorly explained aspect of Clenbuterol use in competitor content:

• Beta-2 receptors downregulate (decrease in number and sensitivity) in response to continuous agonist stimulation — this is a universal feature of G-protein coupled receptor biology, not specific to Clenbuterol
• With continuous Clenbuterol use, beta-2 receptor density decreases by approximately 50% within 2 weeks at consistent doses — the thermogenic and lipolytic effects diminish proportionally
• Clenbuterol's long half-life of ~35-40 hours is critical here: unlike short-acting beta-2 agonists where the receptor can partially recover between doses, Clenbuterol's sustained presence means receptors are continuously occupied, accelerating downregulation
• The 2-week off period allows beta-2 receptor density to upregulate back toward baseline — receptors are resynthesised over this period, restoring sensitivity for the next on-cycle
• Attempting to counteract downregulation by increasing dose provides diminishing returns and increases side effects without proportionally restoring efficacy — the 2-week break remains superior to dose escalation for preserving long-term thermogenic response

Why Clenbuterol Causes Muscle Cramps — The Taurine Mechanism

One of the most consistently asked questions about Clenbuterol and one of the least well-explained:

• Clenbuterol significantly increases taurine excretion via the kidneys — taurine is lost in urine at a rate that often exceeds dietary intake during Clenbuterol use
• Taurine is required for proper calcium handling in skeletal muscle — specifically, it is involved in the regulation of sarcoplasmic reticulum calcium release and re-uptake
• Taurine depletion impairs this calcium regulation, causing muscle cells to have dysregulated calcium cycling — the result is the involuntary, painful muscle contractions (cramps) characteristic of Clenbuterol use
• Practical solution: taurine supplementation at 3-5g/day during Clenbuterol use effectively prevents or significantly reduces cramping in most users — this is not a general electrolyte problem but a specific taurine depletion mechanism

Effects and Benefits

• Increased basal metabolic rate — estimated 5-10% above baseline (approximately 100-200 kcal/day) at therapeutic doses
• Enhanced lipolysis via beta-2 receptor-mediated cAMP/HSL activation in adipose tissue
• Anti-catabolic effect in skeletal muscle — valuable during caloric deficits alongside AAS cycles
• Mild appetite suppression reported by some users due to sympathomimetic activity
• No suppression of natural testosterone — does not require Post Cycle Therapy

Dosage and Administration

Maximum dose: 120-140mcg/day for men; 80-100mcg/day for women — above these thresholds, cardiac side effects become significant without proportional fat loss benefit. Morning dosing is preferred to minimise sleep disruption from sympathomimetic stimulation. Taurine 3-5g/day should be taken throughout to prevent cramping.